David Unwin

David Unwin
Nationality	British
Occupation	General practitioner, author
Title	General practitioner; Royal College of General Practitioners expert clinical adviser in diabetes
Employer	Norwood Surgery, Southport (former)
Known for	Pioneering low-carbohydrate dietary approaches for type 2 diabetes and obesity in primary care

David Unwin is a British general practitioner and author known for developing and popularising a low-carbohydrate dietary approach to the management of type 2 diabetes and obesity within National Health Service primary care. Based for the majority of his career at the Norwood Surgery in Southport, Merseyside, Unwin began experimenting with carbohydrate-restricted advice for patients in the early 2010s after observing that conventional dietary guidance was producing limited results in his diabetic patients. His subsequent work — including the development of patient-facing teaching tools comparing the glycaemic impact of common foods to teaspoons of sugar — has been adopted by clinicians across the United Kingdom and abroad, and has been the subject of peer-reviewed publications, national newspaper features and podcast interviews. Unwin has served as the Royal College of General Practitioners' expert clinical adviser in diabetes and has been recognised on national lists of influential general practitioners. His practice has reported sustained drug-budget savings on diabetes prescribing and, by his account, the remission of type 2 diabetes in scores of patients through lifestyle change alone.

Career

Early years in general practice

Unwin spent the majority of his clinical career as a partner at the Norwood Surgery in Southport, a coastal town in Merseyside, north-west England. For approximately the first quarter-century of his work as a general practitioner he followed mainstream National Health Service guidance for the management of type 2 diabetes and obesity, which at the time emphasised the consumption of starchy carbohydrates as the basis of meals together with medication to control blood glucose. By his own account, the experience of repeatedly seeing patients deteriorate despite adhering to this advice left him increasingly disillusioned with the standard model of diabetes care, in which the disease was widely framed as chronic and progressive.

The turning point in Unwin's clinical thinking came in 2012, when a patient returned to his surgery after a period away and reported that she had placed her type 2 diabetes into remission by following a low-carbohydrate diet she had encountered online. The encounter prompted Unwin to investigate the evidence base for carbohydrate restriction and to begin offering similar advice to other patients with type 2 diabetes who consented to try the approach. The early results he observed — reductions in glycated haemoglobin (HbA1c), weight loss and, in some cases, the withdrawal of diabetes medication — led him to develop a structured programme of dietary advice within his practice.

Low-carbohydrate programme at Norwood Surgery

From 2013 onwards, Unwin systematically offered a low-carbohydrate dietary option to patients at Norwood Surgery with type 2 diabetes, pre-diabetes or obesity. The approach centred on reducing intake of sugar and starchy foods such as bread, rice, pasta, breakfast cereals and potatoes, while emphasising vegetables, eggs, fish, meat, dairy and other lower-carbohydrate foods. Patients were monitored at regular intervals with measurements of weight, blood pressure, HbA1c, liver function and lipid profile, and their medication was adjusted as their metabolic markers improved.

Reporting on Unwin's work in 2023, The Guardian noted that his practice had recorded substantial improvements in patients who adopted the approach, including weight loss, lowered blood glucose and, in a significant proportion of cases, drug-free remission of type 2 diabetes. The newspaper reported that the surgery had achieved drug-budget savings on diabetes prescribing in the region of tens of thousands of pounds per year compared with neighbouring practices of similar size. A 2026 report by the Southport-based outlet Stand Up For Southport stated that 154 of Unwin's patients had reversed their type 2 diabetes under the programme and that, on the basis of these results, he was calling for the NHS to make blood glucose monitors freely available on prescription so that patients could see in real time how different foods affected their glucose levels.

Teaching tools and "sugar equivalents"

A distinctive feature of Unwin's clinical practice has been the use of patient-facing visual tools designed to communicate the glycaemic impact of common foods. The best known of these expresses the estimated effect of a portion of food on blood glucose in terms of an equivalent number of four-gram teaspoons of table sugar. The diagrams, produced in collaboration with his wife, the clinical psychologist Jen Unwin, have been widely reproduced in print and online and translated into multiple languages for use by clinicians outside the United Kingdom.

Unwin has described the rationale for the tools in terms of patient empowerment and informed consent: by translating the carbohydrate content of foods into an intuitive sugar equivalent, patients are able to understand how a meal containing, for example, a large portion of boiled rice or potatoes will affect their blood glucose, and to make their own decisions about diet on that basis. The approach has been positioned by Unwin and collaborators as part of a broader philosophy of what they have termed "hopeful medicine" — clinical practice that frames metabolic disease as potentially reversible through lifestyle change rather than as an inevitably progressive condition requiring escalating medication.

Research and publications

Unwin has co-authored a number of peer-reviewed papers describing the outcomes of the Norwood Surgery programme and related topics. In 2019, a study reported in Diet Doctor and based on data from his practice described substantial reductions in blood pressure among patients following a low-carbohydrate diet, with mean systolic and diastolic readings falling sufficiently for many participants to reduce or discontinue antihypertensive medication.

In 2021, Unwin was among the authors of a paper published in Frontiers in Nutrition titled "Adapting Medication for Type 2 Diabetes to a Low Carbohydrate Diet." The paper provided practical guidance for clinicians on how to adjust medications — including insulin, sulfonylureas, SGLT2 inhibitors, blood pressure medications and diuretics — when patients with type 2 diabetes begin a low-carbohydrate diet, in order to reduce the risks of hypoglycaemia, hypotension and other adverse events as their metabolic parameters change. The paper has been cited internationally as a reference for primary-care clinicians supervising patients undertaking carbohydrate restriction.

Media profile

From the late 2010s onwards Unwin became a frequent commentator in British media on diet, diabetes and obesity. In 2018 he was included on a list of the fifty most influential general practitioners in the United Kingdom compiled by the trade publication Pulse, a recognition reported by Diabetes.co.uk as reflecting the growing reach of his low-carbohydrate approach in primary care.

His profile was raised further by a feature in The Guardian in April 2023, which described his work as pioneering the use of low-carbohydrate dietary advice within the NHS as a means of treating obesity and type 2 diabetes. In May 2026 Unwin appeared as a guest on the podcast The Diary of a CEO, hosted by Steven Bartlett, in a long-form interview focused on fatty liver disease, insulin resistance and the role of diet in metabolic health. The interview was widely circulated online and a full transcript was published by The Singju Post. Unwin's work has also been referenced in coverage of shifting dietary policy in other countries; a 2026 article in Positive News on changes to United States dietary guidelines concerning ultra-processed food cited his arguments about the health effects of refined carbohydrates.

Advocacy and policy

Unwin has used his media profile to campaign for changes in how the NHS manages type 2 diabetes. In January 2026 he publicly called for blood glucose monitors to be made freely available on NHS prescription to people with type 2 diabetes, arguing that real-time feedback on how individual foods affect blood glucose is among the most effective behavioural interventions available to patients and that the costs of providing monitors would be more than offset by savings on diabetes medication and complications. He has also argued that primary-care clinicians should be given the time, training and remuneration structures necessary to offer structured dietary support, rather than being limited to prescribing pharmacological treatments.

Personal Life

Unwin is married to Jen Unwin, a clinical health psychologist. The pair have collaborated extensively on the behavioural and psychological aspects of dietary change, including the development of patient resources and joint authorship of articles on what they describe as "hopeful medicine" — an approach emphasising patient agency, motivation and the possibility of meaningful improvement in chronic metabolic conditions. The couple are based in the Southport area of Merseyside, where Unwin practised as a general practitioner.

Recognition

In 2016, Unwin received the National Health Service Innovator of the Year award for his work on the use of low-carbohydrate diets in primary care, an award noted in subsequent press coverage of his practice. In 2018 he was named on a list of the fifty most influential general practitioners in the United Kingdom, published by the trade journal Pulse and reported by Diabetes.co.uk; the inclusion was cited as evidence of the growing acceptance of carbohydrate restriction as a clinical option within UK primary care.

Unwin has served as the Royal College of General Practitioners' expert clinical adviser in diabetes, a position that has involved contributing to professional education materials and guidance for general practitioners on the management of type 2 diabetes. His papers, including the Frontiers in Nutrition paper on medication adjustment, have been cited internationally by clinicians working with patients on low-carbohydrate diets. Coverage of his work has appeared in The Guardian, the BBC and a range of specialist health publications, and his teaching diagrams comparing the glycaemic impact of common foods to teaspoons of sugar have been translated into multiple languages for use abroad.